Literature DB >> 8763434

Dissecting cellulitis of the scalp: response to isotretinoin.

L Scerri1, H C Williams, B R Allen.   

Abstract

We report three patients with dissecting cellulitis of the scalp. Prolonged treatment with oral isotretinoin was highly effective in all three patients. Furthermore, long-term post-treatment follow-up in two of the patients has shown a sustained therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763434

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  Primary cicatricial alopecia: diagnosis and treatment.

Authors:  Rebecca Filbrandt; Nicholas Rufaut; Leslie Jones; Rodney Sinclair
Journal:  CMAJ       Date:  2013-05-21       Impact factor: 8.262

2.  Dissecting Cellulitis of the Scalp: A Review and Case Studies of Surgical Reconstruction.

Authors:  Trajan A Cuellar; Daniel S Roh; Christian E Sampson
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-08-18

3.  Dissecting Cellulitis of the Scalp Early Diagnosed by Color Doppler Ultrasound.

Authors:  Karina Cataldo-Cerda; Ximena Wortsman
Journal:  Int J Trichology       Date:  2017 Oct-Dec

Review 4.  The Diagnosis and Treatment of Hair and Scalp Diseases.

Authors:  Hans Wolff; Tobias W Fischer; Ulrike Blume-Peytavi
Journal:  Dtsch Arztebl Int       Date:  2016-05-27       Impact factor: 5.594

5.  Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

Authors:  Ediléia Bagatin; Caroline Sousa Costa; Marco Alexandre Dias da Rocha; Fabíola Rosa Picosse; Cristhine Souza Leão Kamamoto; Rodrigo Pirmez; Mayra Ianhez; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2020-10-03       Impact factor: 1.896

6.  Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.

Authors:  Sherman Chu; Lauren Michelle; Chloe Ekelem; Calvin T Sung; Nathan Rojek; Natasha A Mesinkovska
Journal:  Arch Dermatol Res       Date:  2020-11-05       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.